Intravascular lithotripsy safely treats severely calcified coronary-artery disease

Reuters Health - 21/10/2020 - Intravascular lithotripsy (IVL) is a safe and effective adjunct to stent implantation in severely calcified coronary-artery lesions, according to a single-arm multicenter study. "IVL will be the treatment of 'first choice' for moderate-severe coronary calcification to facilitate and optimize stent placement and will apply to about 25% of patients undergoing percutaneous coronary intervention (PCI)," Dr. Dean J. Kereiakes of The Christ Hospital and Lindner Research Center, in Cincinnati, Ohio, told Reuters Health by email. Coronary calcification can impede stent delivery and deployment and can be associated with early complications and/or late adverse events following PCI. Dr. Kereiakes and colleagues in the Disrupt CAD III trial assessed the safety and effectiveness of IVL to optimize stent deployment in patients with severely calcified de novo coronary stenosis. All target lesions in the 384 patients included in the analy...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 21 October, 202028 October, 2020